{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T05:30:15Z","timestamp":1772861415859,"version":"3.50.1"},"reference-count":31,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,9,29]]},"DOI":"10.1536\/ihj.20-126","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T22:04:59Z","timestamp":1599861899000},"page":"865-871","source":"Crossref","is-referenced-by-count":16,"title":["Mid-term Clinical Outcomes of Immediate Protamine Use Following Elective Percutaneous Coronary Interventions"],"prefix":"10.1536","volume":"61","author":[{"given":"Masayuki","family":"Kubota","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Sakakura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousuke","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takunori","family":"Tsukui","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Seguchi","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Wada","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Momomura","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Fujita","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ali ZA, Poludasu S, Qureshi YH, <i>et al<\/i>. Impact of major bleeding on long-term mortality in anemic versus nonanemic patients undergoing percutaneous coronary intervention using bivalirudin. Am J Cardiol 2014; 113: 1481-6.","DOI":"10.1016\/j.amjcard.2014.01.427"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ohno Y, Maekawa Y, Miyata H, <i>et al<\/i>. Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention. J Am Coll Cardiol 2013; 62: 1260-6.","DOI":"10.1016\/j.jacc.2013.03.086"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gayed M, Yadak N, Qamhia W, Daralammouri Y, Ohlow MA. Comorbidities and Complications in Nonagenarians Undergoing Coronary Angiography and Intervention. Int Heart J 2017; 58: 180-4.","DOI":"10.1536\/ihj.16-083"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Das R, Ahmed K, Athanasiou T, Morgan RA, Belli AM. Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis. Cardiovasc Intervent Radiol 2011; 34: 723-38.","DOI":"10.1007\/s00270-010-9981-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Martin JL, Pratsos A, Magargee E, <i>et al<\/i>. A randomized trial comparing compression, Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: the CAP trial. Catheter Cardiovasc Interv 2008; 71: 1-5.","DOI":"10.1002\/ccd.21333"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Baker NC, Ansel GM, Rao SV, <i>et al<\/i>. The choice of arterial access for percutaneous coronary intervention and its impact on outcome: An expert opinion perspective. Am Heart J 2015; 170: 13-22.","DOI":"10.1016\/j.ahj.2015.04.023"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Pan M, Suarez de Lezo J, Medina A, <i>et al<\/i>. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol 1997; 80: 1336-8.","DOI":"10.1016\/S0002-9149(97)00676-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ducas J, Chan MC, Miller A, Kashour T. Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients. Catheter Cardiovasc Interv 2002; 56: 196-9.","DOI":"10.1002\/ccd.10195"},{"key":"9","first-page":"66","volume":"1","year":"2005","unstructured":"9. Thuesen L, Andersen HR, Botker HE, Dalby Kristensen S, Krusell LR, Lassen JF. In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention. EuroIntervention 2005; 1: 66-9.","journal-title":"EuroIntervention","ISSN":"https:\/\/id.crossref.org\/issn\/1774-024X","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamamoto S, Sakakura K, Taniguchi Y, <i>et al<\/i>. Safety of Reversing Anticoagulation by Protamine Following Elective Transfemoral Percutaneous Coronary Intervention in the Drug-Eluting Stent Era. Int Heart J 2018; 59: 482-8.","DOI":"10.1536\/ihj.17-352"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Okuno S, Ishihara T, Iida O, <i>et al<\/i>. Association of Subclinical Intrastent Thrombus Detected 9 Months After Implantation of 2nd-Generation Drug-Eluting Stent With Future Major Adverse Cardiac Events- A Coronary Angioscopic Study. Circ J 2018; 82: 2299-304.","DOI":"10.1253\/circj.CJ-18-0098"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Watanabe Y, Sakakura K, Taniguchi Y, <i>et al<\/i>. Determinants of slow flow following stent implantation in intravascular ultrasound-guided primary percutaneous coronary intervention. Heart Vessels 2018; 33: 226-38.","DOI":"10.1007\/s00380-017-1050-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kasahara T, Sakakura K, Yamamoto K, <i>et al<\/i>. Clinical Factors Associated with In-Hospital Mortality in Patients with Acute Myocardial Infarction Who Required Intra-Aortic Balloon Pumping. Int Heart J 2020; 61: 209-14.","DOI":"10.1536\/ihj.19-368"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Matsuo S, Imai E, Horio M, <i>et al<\/i>. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-92.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"15","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1161\/01.CIR.91.7.1959","volume":"91","year":"1995","unstructured":"15. Mintz GS, Popma JJ, Pichard AD, <i>et al<\/i>. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 1995; 91: 1959-65.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Teramoto T, Tsuchikane E, Matsuo H, <i>et al<\/i>. Initial success rate of percutaneous coronary intervention for chronic total occlusion in a native coronary artery is decreased in patients who underwent previous coronary artery bypass graft surgery. JACC Cardiovasc Interv 2014; 7: 39-46.","DOI":"10.1016\/j.jcin.2013.08.012"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Cutlip DE, Windecker S, Mehran R, <i>et al<\/i>. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115: 2344-51.","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mauri L, Hsieh WH, Massaro JM, Ho KK, D&apos;Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356: 1020-9.","DOI":"10.1056\/NEJMoa067731"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Estrada JR, Paul JD, Shah AP, Nathan S. Overview of Technical and Cost Considerations in Complex Percutaneous Coronary Intervention. Interv Cardiol 2014; 9: 17-22.","DOI":"10.15420\/icr.2011.9.1.17"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wilensky RL, Selzer F, Johnston J, <i>et al<\/i>. Relation of percutaneous coronary intervention of complex lesions to clinical outcomes (from the NHLBI Dynamic Registry). Am J Cardiol 2002; 90: 216-21.","DOI":"10.1016\/S0002-9149(02)02457-8"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Giustino G, Chieffo A, Palmerini T, <i>et al<\/i>. Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI. J Am Coll Cardiol 2016; 68: 1851-64.","DOI":"10.1016\/j.jacc.2016.07.760"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kirtane AJ, Doshi D, Leon MB, <i>et al<\/i>. Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention. Circulation 2016; 134: 422-31.","DOI":"10.1161\/CIRCULATIONAHA.116.022061"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Gaku N, Kengo T, Aoki J, <i>et al<\/i>. Clinical and angiographic outcomes of sirolimus-eluting stents implantation in Japanese patients in daily practice. Circ J 2006; 70: 1367-71.","DOI":"10.1253\/circj.70.1367"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kawaguchi R, Tsurugaya H, Hoshizaki H, Toyama T, Oshima S, Taniguchi K. Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients. Cardiovasc Revasc Med 2008; 9: 2-8.","DOI":"10.1016\/j.carrev.2007.07.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Otsuka F, Cheng Q, Yahagi K, <i>et al<\/i>. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model. JACC Cardiovasc Interv 2015; 8: 1248-60.","DOI":"10.1016\/j.jcin.2015.03.029"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Jinnouchi H, Mori H, Cheng Q, <i>et al<\/i>. Thromboresistance and functional healing in the COBRA PzF stent versus competitor DES: implications for dual antiplatelet therapy. EuroIntervention 2019; 15: e342-53.","DOI":"10.4244\/EIJ-D-18-00740"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Prati F, Romagnoli E, Gatto L, <i>et al<\/i>. Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque\/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L&apos;Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome). Circ Cardiovasc Interv 2016; 9: e003726.","DOI":"10.1161\/CIRCINTERVENTIONS.115.003726"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Moscucci M, Fox KA, Cannon CP, <i>et al<\/i>. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003; 24: 1815-23.","DOI":"10.1016\/S0195-668X(03)00485-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Tamanaha Y, Sakakura K, Taniguchi Y, <i>et al<\/i>. Comparison of Postcatheterization Pseudoaneurysm between Brachial Access and Femoral Access. Int Heart J 2019; 60: 1030-6.","DOI":"10.1536\/ihj.18-551"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996; 49: 1373-9.","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Stoltzfus JC. Logistic regression: a brief primer. Acad Emerg Med 2011; 18: 1099-104.","DOI":"10.1111\/j.1553-2712.2011.01185.x"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-126\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:56:35Z","timestamp":1601697395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-126\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-126","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}